SEP 23, 2021 11:00 AM PDT

Updates on Primary Aldosteronism Screening and Use of Direct Renin

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Pathology Laboratory Utilization Manager, Special Testing Manager, Physician/Laboratory Consultant, Director of Specimen Referral, Adjunct Assistant Professor
    BIOGRAPHY

Abstract
Date:  September 23, 2021
Time: 11:00am (PDT),  2:00pm (EDT)
 
Primary aldosteronism (PA) is the most common form of secondary hypertension, caused by hyperactivity in one or both of the adrenal glands that leads to inappropriate aldosterone production. The prevalence of PA among general and resistant hypertensive populations ranges from 5-20%. PA is considered highly treatable and potentially curable. As such, the Endocrine Society guidelines recommend screening for PA in high risk populations using the plasma aldosterone/plasma renin ratio (ARR). It is generally accepted that both the plasma renin and aldosterone levels tend to fall with advancing age and plasma renin decreases more than aldosterone; consequently, the ARR increases in the elderly which supports the need for age-specific ARR cutoffs. Traditionally, renin has been measured by a plasma renin activity (PRA) radioimmunoassay or liquid chromatography tandem mass spectrometry (LC-MS/MS). Direct renin concentration (DRC) immunoassays, also known as plasma renin concentration (PRC), have recently become more popular because of numerous benefits including walk-away automation, shorter turnaround times, and excellent reproducibility compared to PRA. In this webinar, we will review the key differences between PRA and DRC assays and discuss the utility of proposed age-specific ARR cutoffs for PA screening calculated using direct renin measurement.
 
 
Learning Objectives:
 
  • Provide an overview of the renin-angiotensin-aldosterone system (RAAS) and implication on Hypertension.
  • Describe and understand key differences between plasma renin activity (PRA) assays and direct renin concentration (DRC) assays.
  • Discuss proposed age-specific plasma aldosterone/plasma renin ratio (ARR) cutoffs for PA screening calculated using DRC.
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAR 29, 2022 9:00 AM PDT
C.E. CREDITS
MAR 29, 2022 9:00 AM PDT
Date: March 29, 2022 Time: 09:00am (PDT), 12:00pm (EDT), 17:00 (GMT) Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clin...
FEB 24, 2022 9:00 AM PST
C.E. CREDITS
FEB 24, 2022 9:00 AM PST
Date: February 24, 2021 Time: 9:00am (PST), 12:00pm (EST) Cytokine profiling is a valuable tool used in preclinical research for monitoring an immune response and cell signaling pathways dur...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
C.E. CREDITS
In-house testing is not required federally; however, states differ in their requirements. Cannabis extraction laboratories need to test extracts for pesticides, heavy metals, residual solven...
Loading Comments...
Show Resources